• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 5. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020

Introduction to 2-(Propan-2-yl)-1H-imidazole-4-carboxylic Acid (CAS No. 102625-27-4)

2-(Propan-2-yl)-1H-imidazole-4-carboxylic Acid, identified by the Chemical Abstracts Service Number (CAS No.) 102625-27-4, is a significant compound in the realm of pharmaceutical and biochemical research. This heterocyclic organic molecule belongs to the imidazole class, characterized by a five-membered ring containing two nitrogen atoms. The presence of a propyl group at the 2-position and a carboxylic acid moiety at the 4-position imparts unique chemical and biological properties, making it a valuable scaffold for drug discovery and molecular studies.

The structure of 2-(Propan-2-yl)-1H-imidazole-4-carboxylic Acid (CAS No. 102625-27-4) consists of an imidazole core, which is a privileged scaffold in medicinal chemistry due to its ability to interact with biological targets such as enzymes and receptors. The propyl group enhances lipophilicity, facilitating cellular uptake, while the carboxylic acid group allows for further functionalization, enabling the synthesis of derivatives with tailored properties. These features make it a versatile building block in the development of novel therapeutic agents.

In recent years, there has been growing interest in imidazole derivatives as pharmacological tools. The compound 2-(Propan-2-yl)-1H-imidazole-4-carboxylic Acid (CAS No. 102625-27-4) has been explored in various contexts, particularly in the search for compounds with anti-inflammatory, antimicrobial, and anticancer activities. Its structural motif is reminiscent of several known bioactive molecules, suggesting potential therapeutic applications.

One of the most compelling aspects of 2-(Propan-2-yl)-1H-imidazole-4-carboxylic Acid (CAS No. 102625-27-4) is its role as a precursor in synthesizing more complex molecules. Researchers have leveraged its reactive sites to create libraries of derivatives, employing techniques such as Suzuki-Miyaura cross-coupling and esterification reactions. These methodologies have led to the identification of compounds with enhanced binding affinity and selectivity towards target proteins.

The pharmaceutical industry has also shown interest in this compound due to its potential as an intermediate in the synthesis of small-molecule drugs. Its compatibility with various functional groups allows for seamless integration into larger molecular frameworks, making it a valuable asset in drug development pipelines. Additionally, its stability under standard conditions ensures that it can be stored and handled without significant degradation, further enhancing its utility.

Recent studies have highlighted the compound's significance in medicinal chemistry through its application in high-throughput screening (HTS) campaigns. By incorporating 2-(Propan-2-yl)-1H-imidazole-4-carboxylic Acid (CAS No. 102625-27-4) into virtual screening libraries, researchers have identified novel hits that exhibit promising biological activity. These hits have served as starting points for structure-based drug design, leading to the development of lead compounds with therapeutic potential.

The versatility of 2-(Propan-2-yl)-1H-imidazole-4-carboxylic Acid (CAS No. 102625-27-4) extends beyond pharmaceutical applications; it has also been utilized in biochemical research to probe enzyme mechanisms and interactions. Its ability to act as a competitive inhibitor or substrate for certain enzymes has provided insights into metabolic pathways and disease mechanisms. This underscores its importance not only as a synthetic intermediate but also as a tool for understanding biological processes at a molecular level.

In conclusion, 2-(Propan-2-yl)-1H-imidazole-4-carboxylic Acid (CAS No. 102625-27-4) represents a fascinating compound with broad applications in pharmaceutical and biochemical research. Its unique structural features and reactivity make it an indispensable tool for drug discovery efforts aimed at addressing unmet medical needs. As research continues to uncover new therapeutic targets and methodologies, this compound is poised to remain at the forefront of molecular innovation.

• 172875-52-4(2-propyl-1H-imidazole-5-carboxylic acid)
• 84255-21-0(2-Ethyl-1H-imidazole-5-carboxylic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)